S-35225 decreases plasma PAI-1 activity both in vitro and in vivo

被引：0
|
作者：
Rupin, A. [1 ]
Gaertner, R. [1 ]
Mennecier, P. [1 ]
Benoist, A. [2 ]
De Nanteuil, G. [2 ]
Verbeuren, T. [1 ]
机构：
[1] Inst Rech Servier, Div Angiol, Suresnes, France
[2] Inst Rech Servier, Div Chem, Suresnes, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2006年 / 4卷
关键词：
PAI-1; inhibitor; activity; thrombolytic therapy;
D O I：
10.1111/j.1538-7836.2006.00171.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
171
引用
收藏
页码：166 / 166
页数：1
相关论文
共 41 条
  • [31] FTY720 Shows Promising In vitro and In vivo Preclinical Activity by Downmodulating Cyclin D1 and Phospho-Akt in Mantle Cell Lymphoma
    Liu, Qing
    Alinari, Lapo
    Chen, Ching-Shih
    Yan, Fengting
    Dalton, James T.
    Lapalombella, Rosa
    Zhang, Xiaoli
    Mani, Rajeswaran
    Lin, Teresa
    Byrd, John C.
    Baiocchi, Robert A.
    Muthusamy, Natarajan
    CLINICAL CANCER RESEARCH, 2010, 16 (12) : 3182 - 3192
  • [32] In vivo Role of Cytochrome P450 2E1 and Glutathione-S-Transferase Activity for Acrylamide Toxicokinetics in Humans
    Doroshyenko, Oxana
    Fuhr, Uwe
    Kunz, Daria
    Frank, Dorothee
    Kinzig, Martina
    Jetter, Alexander
    Reith, Yvonne
    Lazar, Andreas
    Taubert, Dirk
    Kirchheiner, Julia
    Baum, Matthias
    Eisenbrand, Gerhard
    Berger, Franz-Ingo
    Bertow, Daniel
    Berkessel, Albrecht
    Soergel, Fritz
    Schoemig, Edgar
    Tomalik-Scharte, Dorota
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (02) : 433 - 443
  • [33] Novel inhibitors targeting the PGK1 metabolic enzyme in glycolysis exhibit effective antitumor activity against kidney renal clear cell carcinoma in vitro and in vivo
    He, Yu
    Luo, Yinheng
    Huang, Lan
    Zhang, Dan
    Hou, Huijin
    Liang, Yue
    Deng, Shi
    Zhang, Peng
    Liang, Shufang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 267
  • [34] Inhibition of steroid sulfatase activity and cell proliferation in ZR-75-1 and BT-474 human breast cancer cells by KW-2581 in vitro and in vivo
    Hiroyuki Ishida
    Taisuke Nakata
    Natsuko Sato
    Pui-Kai Li
    Takashi Kuwabara
    Shiro Akinaga
    Breast Cancer Research and Treatment, 2007, 104 : 211 - 219
  • [35] Inhibition of steroid sulfatase activity and cell proliferation in ZR-75-1 and BT-474 human breast cancer cells by KW-2581 in vitro and in vivo
    Ishida, Hiroyuki
    Nakata, Taisuke
    Sato, Natsuko
    Li, Pui-Kai
    Kuwabara, Takashi
    Akinaga, Shiro
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 104 (02) : 211 - 219
  • [36] Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo
    Kim, Kihyun
    Kong, Sun-Young
    Fulciniti, Mariateresa
    Li, Xianfeng
    Song, Weihua
    Nahar, Sabikun
    Burger, Peter
    Rumizen, Mathew J.
    Podar, Klaus
    Chauhan, Dharminder
    Hideshima, Teru
    Munshi, Nikhil C.
    Richardson, Paul
    Clark, Ann
    Ogden, Janet
    Goutopoulos, Andreas
    Rastelli, Luca
    Anderson, Kenneth C.
    Tai, Yu-Tzu
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (04) : 537 - 549
  • [37] The JNK Signaling Pathway Is a Novel Molecular Target for S-Propargyl-L-Cysteine, a Naturally-Occurring Garlic Derivatives: Link to Its Anticancer Activity in Pancreatic Cancer In Vitro and In Vivo
    Wang, Wei
    Cheng, Jianwen
    Zhu, Yizhun
    CURRENT CANCER DRUG TARGETS, 2015, 15 (07) : 613 - 623
  • [38] Investigation for antimicrobial resistance-modulating activity of diethyl malate and 1-methyl malate against beta-lactamase class A from Bacillus licheniformis by molecular dynamics, in vitro and in vivo studies
    Mirzaie, Sako
    Najafi, Kambiz
    Hakhamaneshi, Mohammad Saeed
    Shahverdi, Ahmad Reza
    Fathi, Fardin
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2015, 33 (05) : 1016 - 1026
  • [39] Identification of Functional MKK3/6 and MEK1/2 Homologs from Echinococcus granulosus and Investigation of Protoscolecidal Activity of Mitogen-Activated Protein Kinase Signaling Pathway Inhibitors In Vitro and In Vivo
    Zhang, Chuanshan
    Li, Jing
    Aji, Tuerganaili
    Li, Liang
    Bi, Xiaojuan
    Yang, Ning
    Li, Zhide
    Wang, Hui
    Mao, Rui
    Lu, Guodong
    Shao, Yingmei
    Vuitton, Dominique A.
    Wen, Hao
    Lin, Renyong
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (01)
  • [40] The MEK 1/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM-coated PLGA-PEG nanoparticles
    Wiwatchaitawee, Kanawat
    Mekkawy, Aml I.
    Quarterman, Juliana C.
    Naguib, Youssef W.
    Ebeid, Kareem
    Geary, Sean M.
    Salem, Aliasger K.
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2022, 12 (07) : 1684 - 1696
12345